A new concept in prophylaxis and therapy: paramunization by poxvirus inducers

被引:11
|
作者
Mayr, A [1 ]
Mayr, B [1 ]
机构
[1] Univ Munich, Tierarztliche Fak, Lehrstuhl Mikrobiol & Seuchenlehre, D-80539 Munich, Germany
来源
PESQUISA VETERINARIA BRASILEIRA | 1999年 / 19卷 / 3-4期
关键词
paramunization; paramunity inducer; pox viruses; therapy; prophylaxis;
D O I
10.1590/S0100-736X1999000300001
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The so-called primitive, innate or paraspecific immune system is the phylogenetically older part of the complex immune system. It enables the organism to immediately attack various foreign substances, infectious pathogens, toxins and transformed cells of the organism itself. "Paramunity" is defined as an optimal regulated and activated, antigen-nonspecific defence, acquired through continuous active and succesful confrontation with endogenous and exogenous noxes or by means of "paramunization" with so called "paramunity inducers" Paramunity inducers based on different pox virus species (e.g. Baypamun(R), Duphapind(R), Conpind) have turned out to be effective and safe when applied with human beings as well as with animals. Pox virus inducers activate phagocytosis and NK-cells in addition to regulation of various cytokines, notably interferon a and g, IL 1, 2, CSF and TNF which comprise the network of the complex paraspecific immune system. The results of experimental work as well as practical use in veterinary medicine have shown that paramunization by pox inducers goes far beyond the common understanding of so-called "immuno-therapy". They are "bioregulators", because they have 1. a regulatory effect on a disturbed immune system in the sense of an optimal homoeostasis, and 2. simultaneously a regulatory effect between the immune, nervous, circulatory and hormone system. Therefore, the use of paramunization by pox inducers opens a new way of prophylaxis and therapy, not only with regard to infections, but also with regard to different other indications.
引用
收藏
页码:91 / 98
页数:8
相关论文
共 50 条
  • [31] MALARIA - NEW DEVELOPMENTS IN PROPHYLAXIS, DIAGNOSIS AND THERAPY
    SHAH, PM
    MEDIZINISCHE WELT, 1993, 44 (08): : 468 - 471
  • [32] GERIATRIC HYPOADRENOCORTICISM - NEW PROSPECTS FOR PROPHYLAXIS AND THERAPY
    RUGGIERI, G
    LINGETTI, M
    PATANE, S
    DISTEFANO, F
    POLICICCHIO, D
    CIARIMBOLI, M
    DIGREZIA, F
    ROTONDIAUFIERO, F
    GIORNALE DI GERONTOLOGIA, 1978, 26 (04) : 241 - 255
  • [33] A new chance for hormone therapy in cardiological prophylaxis?
    Kornacewicz-Jach, Zdzislawa
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2007, 6 (04): : 189 - 194
  • [34] NEW ASPECTS OF THERAPY AND PROPHYLAXIS OF VIRUS HEPATITIS
    MULLER, R
    LEBER MAGEN DARM, 1977, 7 (05) : 295 - 299
  • [35] A new concept: Differentiation therapy in malignancies
    Degos, L
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 1995, 179 (08): : 1689 - 1700
  • [36] SOCIAL THERAPY - A NEW ACTION CONCEPT
    DORST, B
    LEFFERS, CJ
    GRUPPENPSYCHOTHERAPIE UND GRUPPENDYNAMIK, 1980, 15 (1-2) : 91 - 114
  • [37] NEW THERAPY CONCEPT FOR THE VAGINAL FLORA
    KARKUT, G
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1984, 44 (06) : 409 - 409
  • [38] A new concept in therapy of esthesioneuroblastoma.
    Walch, C
    Stammberger, H
    Unger, F
    Anderhuber, W
    LARYNGO-RHINO-OTOLOGIE, 2000, 79 (12): : 743 - 748
  • [39] Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: Pathogenesis, prophylaxis, and antiviral therapy
    Chen, Nanhai
    Bellone, Clifford J.
    Schriewer, Jill
    Owens, Gelita
    Fredrickson, Torgny
    Parker, Scott
    Buller, R. Mark L.
    VIROLOGY, 2011, 409 (02) : 328 - 337